重塑阿尔茨海默病中的β-淀粉样蛋白累积曲线?纵向淀粉样蛋白PET数据的部分容积效应校正
本研究对216例症状性阿尔茨海默病连续谱(淀粉样蛋白阳性)患者进行纵向分析,比较部分容积效应校正(PVEC)前后β-淀粉样蛋白PET累积曲线的形状。PVEC后区域和复合SUV比值随时间的变化显著高于未校正数据(复合SUVR P=0.0002),且与简易精神状态检查下降相关的SUVR变化斜率在PVEC后显著更高(F1=7.1,P=0.008)。结论提示β-淀粉样蛋白累积曲线在早期症状阶段并未达到平台期。
要点
- PVEC后复合SUVR随时间变化显著高于未校正数据(P=0.0002)。
- PVEC后SUVR变化与MMSE下降的回归斜率显著高于未校正数据(F1=7.1,P=0.008)。
- 结果提示β-淀粉样蛋白累积曲线在早期症状阶段并未达到平台期。
核心结论
- PVEC结果提示β-淀粉样蛋白累积曲线在早期症状性疾病阶段并未达到平台期。
- 作者认为有必要进一步评估PVEC对体内刻画时间依赖性AD病理的影响,包括对其他淀粉样蛋白示踪剂的可靠评估和比较。
研究设计与样本
- 本研究为淀粉样蛋白敏感PET数据的纵向分析,纳入阿尔茨海默病神经影像学倡议中216例症状性AD连续谱且淀粉样蛋白阳性个体(17例AD痴呆和199例轻度认知障碍)。
- 分析基线及2年随访数据,包括18F-florbetapir PET、MRI和简易精神状态检查评分;PVEC采用改良Müller-Gärtner方法。
主要发现
- 与未行PVE校正的数据相比,PVE校正数据随时间产生的区域和复合SUV比值变化显著更高(复合SUVR P=0.0002)。
- PVE校正PET数据中,SUVR纵向变化与简易精神状态检查下降关系的回归线斜率显著高于未校正PET数据(F1=7.1,P=0.008)。
局限性
- 作者认为有必要进一步评估PVEC对体内刻画时间依赖性AD病理的影响,包括对其他淀粉样蛋白示踪剂的可靠评估和比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
It was hypothesized that the brain β-amyloid buildup curve plateaus at an early symptomatic stage of Alzheimer disease (AD). Atrophy-related partial-volume effects (PVEs) degrade signal in hot-spot imaging techniques such as amyloid PET. The current study, a longitudinal analysis of amyloid-sensitive PET data, investigated the effect on the shape of the β-amyloid curve in AD when PVE correction (PVEC) is applied. Methods: We analyzed baseline and 2-y follow-up data for 216 symptomatic individuals on the AD continuum (positive amyloid status) enrolled in the Alzheimer's Disease Neuroimaging Initiative (17 with AD dementia and 199 with mild cognitive impairment), including 18F-florbetapir PET, MRI, and Mini Mental State Examination scores. For PVEC, the modified Müller-Gärtner method was performed. Results: Compared with non-PVE-corrected data, PVE-corrected data yielded significantly higher changes in regional and composite SUV ratio (SUVR) over time (P = 0.0002 for composite SUVRs). Longitudinal SUVR changes in relation to Mini Mental State Examination decreases showed a significantly higher slope for the regression line in the PVE-corrected than in the non-PVE-corrected PET data (F1 = 7.1, P = 0.008). Conclusion: These PVEC results indicate that the β-amyloid buildup curve does not plateau at an early symptomatic disease stage. A further evaluation of the impact of PVEC on the in vivo characterization of time-dependent AD pathology, including the reliable assessment and comparison of other amyloid tracers, is warranted.
引用
- Rullmann M, McLeod A, Grothe MJ, et al. Reshaping the Amyloid Buildup Curve in Alzheimer Disease? Partial-Volume Effect Correction of Longitudinal Amyloid PET Data. J Nucl Med. 2020. PMID: 32358089. doi:10.2967/jnumed.119.238477
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。